Future studies will also examine whether initiating treatment at this time point improves skeletal microarchitecture and mechanical properties at a later time point representing ESKD, which may point to the efficacy of lowering PTH earlier in the disease course of CKD. The gene discussed is PTH; the disease is chronic kidney disease.